A.R.T. Advisors’s TherapeuticsMD TXMD Stock Holding History

A.R.T. Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,211	Closed	-$268K	–	936
2019 Q4	$268K	Buy	+2,211	New	+$318K	0.01%	1065
2019 Q3	–	Sell	-3,196	Closed	-$416K	–	1744
2019 Q2	$416K	Buy	3,196 +1,118	+54%	+$200K	0.02%	820
2019 Q1	$506K	Buy	+2,078	New	+$550K	0.03%	738
2018 Q4	–	Sell	-3,222	Closed	-$1.06M	–	1661
2018 Q3	$1.06M	Buy	3,222 +1,146	+55%	+$351K	0.05%	557
2018 Q2	$647K	Buy	+2,076	New	+$634K	0.03%	819
2018 Q1	–	Sell	-2,456	Closed	-$741K	–	1772
2017 Q4	$741K	Buy	+2,456	New	+$684K	0.03%	739
2017 Q2	–	Sell	-3,872	Closed	-$1.39M	–	1733
2017 Q1	$1.39M	Buy	3,872 +1,006	+35%	+$311K	0.06%	438
2016 Q4	$826K	Buy	+2,866	New	+$888K	0.05%	544

Other funds holding TXMD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

A.R.T. Advisors's TXMD Position: Q1 2020 in Review

A.R.T. Advisors sold out of TherapeuticsMD (TXMD) in Q1 2020, closing a stake of 2,211 shares — an estimated $268K sold.

A.R.T. Advisors first reported a position in TXMD in Q4 2016 and held it in 8 quarters. The position peaked at $1.39M in Q1 2017. 143 funds tracked by Wall St. Rank hold TXMD as of Q1 2020.

A.R.T. Advisors reported no remaining TherapeuticsMD position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 2,211 TherapeuticsMD shares in Q1 2020, an estimated $268K.
A.R.T. Advisors first reported a position in TherapeuticsMD in Q4 2016 and held it in 8 quarters.
A.R.T. Advisors's TherapeuticsMD position peaked at $1.39M in Q1 2017.
143 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.